Login Register

CEO discusses expansion of cancer biomarker technology research program and future commercialization plans with University of York collaboration | Allan Syms,CEO, Cizzle Biotechnology Holdings PLC. 00:10:00

Share On Facebook Share On Twitter

The CEO of Cizzle biotech provides insights into the expansion of their cancer biomarker technology research program in collaboration with the University of York, detailing future steps towards commercialization and regulatory approvals.

Recent Videos

00:10:00
Sustaining Success: Spinning Mills MD on Global Yarn and Fabric Promotion at Asian Trade Exhibition|Mr. S. Dinakaran,Managing Director,Sambandam Spinning Mills Ltd.
00:10:00
Resolute Mining: CEO Terry Hulahan on Overcoming Challenges and Gold Production Growth in West Africa|Terry Holohan,Managing Director and Chief Executive Officer,Resolute Mining Ltd.
00:10:00
Expanding Horizons: Financial Strength and Growth Strategy in Innovation, Biologics, and Consumer Care|Erez Israeli,Chief Executive Officer,Dr. Reddy's Laboratories Ltd
00:10:00
Phost's Breakthrough in Neurodegenerative Disease Treatment: CEO Michael Thern on Accelerated FDA Approval for Monipentel|Dr Michael Thurn,Managing Director & Chief Executive Officer,PharmAust Ltd.
00:10:00
Navigating Raw Material Challenges: Tire Industry Demand and Growth Outlook for 2023|Mr. Suresh Sodani,Managing Director,Century Enka Ltd
00:10:00
Tilaknagar Industries' Financial Turnaround: Chairman Amit Dhanuka on Overcoming Stress and Achieving Profitability|Amit Dahanukar,Chairman and Managing Director,Tilaknagar Industries Ltd.
00:10:00
Bajaj Electricals' Summer Campaigns: 'Fan Nahi, Fantastic' and Air Coolers Strategy Amid Post-Pandemic Recovery| ANUJ PODDAR,Managing Director & CEO,Bajaj Electricals Ltd.
00:10:00
Insights from Rajitha Kariyawasan: Hayleys Group MD on Leadership and Six Sigma Excellence|RAJITHA KARIYAWASAN,Managing Director,Haycarb Plc
00:10:00
Exploring Company Achievements: Insights on Water Tank Success and Future Prospects|LALIT DAMODAR MEHTA,Managing Director,Samrat Pharmachem Ltd.
00:10:00
Keys to Success: Innovation, Punctuality, and Leadership Insights for Business Growth|Roshan Rajadurai,Managing Director,Hayleys Plc
00:10:00
Empowering Small Farmers: Sri Lankan Agriculture Reaching Global Markets|Sarath Ganegoda,Executive Director,Hayleys Fibre PLC
00:10:00
Central Banks' Focus: Tackling Inflation Through Interest Rate Adjustments|E L (Lesetja) Kganyago,GOVERNOR,South African Reserve Bank
00:10:00
Five Decades in Construction: Iconic Projects and Milestones of Gayatri Group|Mr. T V Sandeep Kumar Reddy ,Chairman,Gayatri BioOrganics Ltd.
00:10:00
From Humble Beginnings to Success: Meet Lalit Dangi, Chairman of Liquid Group|Mr. Lalit Kumar Dangi,Chairman,Libord Securities Ltd.
00:10:00
Shakti Pumps: Revolutionizing Irrigation for Indian Farmers Since 1982|Mr. Dinesh Patidar,Managing Director,Shakti Pumps (India) Ltd.
00:10:00
Adapting to New Business Realities in South Africa: Challenges and Resilience Amid Logistics and Energy Constraints|DR NOMBASA TSENGWA,CHIEF EXECUTIVE OFFICER,Exxaro Resources Ltd.

Suggestions

00:00:00
Diffusion Pharmaceuticals Inc. Overview - David Kalergis, CEO, Diffusion Pharmaceuticals
00:10:00
Ex-Hyflux CEO Olivia Lum and ex-CFO, along with four others, charged in court amid corporate governance issues.
00:10:00
Highlights from BLTG Capital Markets Day on June 3, 2020 | Matt Jones, CEO, Blancco Technology Group PLCBLTG:LSE
00:10:00
Day in the Life: Dangote's Top Customer 2014 | Arvind Pathak - Managing Director of Dangote Cement Plc
00:10:00
Preparing for Shareholder Activism: Smart Risk Management Strategies
00:10:00
Arçelik CEO Hakan Bulgurlu Reveals the Career-Defining Lesson He Learned as a Young Jeweler’s Assistant | Hakan Bulgurlu, CEO, Arçelik AS.
00:10:00
A TOTAL SOLUTION FROM EXTRACTION TO DETECTION|Dr. Chang, Chairman,TBG Diagnostics Ltd
00:10:00
Believes in giving their all for their portfolio companies across all stages|David Skok,General Partner,Matrix Partners
00:10:00
Addressing Legal and Ethical Challenges in Targeted Killing: A Conceptual Framework|Abraham D. Sofaer
00:10:00
Development of a new generation of immune response modifier|Simon Wilkinson,CEO,Innate Immunotherapeutics Ltd
00:10:00
Hunter invests in most industries outside of biotech|Hunter Walk,General Partner, Homebrew
00:10:00
Bruce Richards, Founder Chairman and CEO of Marathon Asset Management, shares insights on market conditions on 'Closing Bell'.

© 2017 - Townhall + Tv